$CCEP

Coca-Cola Europacific Partners (CCEP) repurchased 199,209 shares from 19-23 Oct 2026 as part of its EUR 1B share buyback program. The shares were bought from Goldman Sachs on US and London trading venues and will be cancelled. CCEP is listed on multiple exchanges, including NASDAQ and LSE, under the symbol CCEP.

Coca-Cola Europacific Partners (CCEP) invested $39.7M to upgrade its Kewdale manufacturing facility, adding a new can line that boosts production capacity by over 40%. The upgrade supports local jobs and meets growing demand in Western Australia. CCEP also launched a workforce pilot to attract more people into manufacturing careers, receiving 900 applications for its first intake.

Coca-Cola Europacific Partners (CCEP) repurchased 187,946 shares (138,046 in the US, 49,900 in London) from 12-16 October 2026, spending up to EUR 1B under its buyback program. Shares were bought at prices ranging from USD 103.93 to 111.60 and GBP 78.60 to 84.15, with volume-weighted averages provided. CCEP is listed on multiple exchanges, including NASDAQ and the London Stock Exchange, under the ticker CCEP.

Coca-Cola Europacific Partners Australia (CCEP) announced Orlando Rodriguez will depart in early 2027. Miles Karemacher, currently General Manager, Italy for Coca-Cola HBC, will replace him as Managing Director, Australia, effective 18 January 2027. Rodriguez led CCEP Australia through growth and transformation since 2019. Karemacher brings extensive experience in the Coca-Cola system and consumer goods industry.

Coca-Cola Europacific Partners invested $39.7m in its Kewdale plant, adding a can line to boost capacity by 40%. The upgrade supports local demand, efficiency, and jobs, with the line producing 16m cases annually. The company also launched a workforce pilot for flexible part-time roles, attracting 900 applicants.

Coca-Cola Europacific Partners (CCEP) repurchased 198,944 ordinary shares from 5-9 October 2026, as part of its EUR 1 billion share buyback programme announced in February 2026. The repurchased shares will be cancelled. CCEP is listed on multiple exchanges, including Euronext Amsterdam, NASDAQ, and the London Stock Exchange, under the symbol CCEP.

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

Coca-Cola Europacific Partners (CCEP) repurchased 200,000 shares from 28 Sep to 2 Oct 2026, split between US and London venues, at varying prices. The buyback is part of a EUR 1 billion program announced in Feb 2026. The shares will be cancelled.

UBS reports European retail beer volumes fell 3.1% in the four weeks ended Sept. 6, reversing prior growth. Soft drinks slowed to 1.4% growth, while spirits declined 4.9%. Heineken, Carlsberg, and Anheuser-Busch InBev saw volume changes. Diageo, Pernod, Campari, and Remy reported mixed spirits sales. Coca-Cola Europacific Partners and others saw slower non-alcoholic drink growth.

Coca-Cola Europacific Partners (CCEP) filed a Form 6-K with the SEC, disclosing share acquisitions by executives. CFO Edward Walker, General Counsel Svetlana Walker, and Chief Commercial Officer Stephen Lusk each acquired shares under the UK Share Plan and UK Shareshop. The transactions occurred on September 21, 2026, on the Nasdaq Stock Market.